YKL-40 regulated epithelial-mesenchymal transition and migration/invasion enhancement in non-small cell lung cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
YKL-40 regulated epithelial-mesenchymal transition and migration/invasion enhancement in non-small cell lung cancer
Authors
Keywords
Reverse Transcription Polymerase Chain Reaction, NSCLC Patient, NSCLC Cell, NSCLC Cell Line, NSCLC Patient Prognosis
Journal
BMC CANCER
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-08-15
DOI
10.1186/s12885-015-1592-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer
- (2013) I. Canadas et al. CLINICAL CANCER RESEARCH
- YKL-40 and EGFR is a good biomarker for predicting nodal metastasis in anal carcinoma
- (2013) Y. Yang et al. Colorectal Disease
- YKL-40 acts as an angiogenic factor to promote tumor angiogenesis
- (2013) Rong Shao Frontiers in Physiology
- Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and Injury
- (2011) Chun Geun Lee et al. Annual Review of Physiology
- Carbohydrate-binding motif in chitinase 3-like 1 (CHI3L1/YKL-40) specifically activates Akt signaling pathway in colonic epithelial cells
- (2011) Chun-Chuan Chen et al. CLINICAL IMMUNOLOGY
- Can YKL-40 be a new inflammatory biomarker in cardiovascular disease?
- (2011) Jens Kastrup IMMUNOBIOLOGY
- Role of YKL-40 in the Angiogenesis, Radioresistance, and Progression of Glioblastoma
- (2011) Ralph A. Francescone et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A YKL-40-Neutralizing Antibody Blocks Tumor Angiogenesis and Progression: A Potential Therapeutic Agent in Cancers
- (2011) M. Faibish et al. MOLECULAR CANCER THERAPEUTICS
- Expression of pERK and pAKT in pediatric high grade astrocytomas: Correlation with YKL40 and prognostic significance
- (2011) Manila Antonelli et al. NEUROPATHOLOGY
- Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer
- (2010) Ina Thöm et al. CANCER
- CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells
- (2010) Bo Mi Ku et al. INTERNATIONAL JOURNAL OF CANCER
- The Chitinase-like Protein YKL-40 Is Secreted by Airway Epithelial Cells at Base Line and in Response to Compressive Mechanical Stress
- (2010) Jin-Ah Park et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases
- (2010) Dafna Bonneh-Barkay et al. Journal of Neuroinflammation
- PrognoScan: a new database for meta-analysis of the prognostic value of genes
- (2009) Hideaki Mizuno et al. BMC Medical Genomics
- Prognostic significance of epithelial–mesenchymal transition in malignant pleural mesothelioma☆☆☆
- (2009) Alexandra Schramm et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Prognostic gene signatures for non-small-cell lung cancer
- (2009) Paul C. Boutros et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Potential role of chitinase 3-like-1 in inflammationassociated carcinogenic changes of epithelial cells
- (2009) Katrin Eurich et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Selective repression of YKL-40 by NF-κB in glioma cell lines involves recruitment of histone deacetylase-1 and -2
- (2008) Krishna P. Bhat et al. FEBS LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation